Federal Register / Vol. 77, No. 13 / Friday, January 20, 2012 / Notices 2983 

individual submissions, but will 

consider all suggestions. 

ADDRESSES: Electronic submissions are 

encouraged, preferably as an email with 

an electronic file in a standard word 

processing format as an email 

attachment. Submissions may also be in 

the form of a letter to: Maushami 

DeSoto, Ph.D., MHA, Staff Service 

Fellow, Office of Extramural Research, 

Education and Priority Populations, 

Agency for Healthcare Research and 

Quality, 540 Gaither Rd., Rockville, MD 

20850, Phone: (301) 427–1546, Fax: 

(301) 427–1238, Email: Maushami.

DesotoAHRQ.hhs.gov. 

All submissions must include a 

written statement from the submitter 

that it will grant AHRQ the necessary 

rights to use, modify, and adapt the 

submitted instruments, items, and their 

documentation for the development of 

this survey and its dissemination for 

AHRQ purposes. In accordance with 

CHIPRA’s charge to improve pediatric 

quality care measures, and consistent 

with AHRQ’s mandate to disseminate 

research results, 42 U.S.C. 299c–3, 

AHRQ purposes include public 

disclosure and dissemination (e.g., on 

the AHRQ Web site) of AHRQ products 

and the results of AHRQ-sponsored 

research and activities. The written 

statement must be signed by an 

individual authorized to act for any 

holder of copyright and/or data rights 

on each submitted measure or 

instrument. The authority of the 

signatory to provide such authorization 

should be described in the letter. 

Submitters must attach a proposed 

license granting all of the abovereferenced rights, including the 

following terms: 

• A worldwide, royalty-free, 

nonexclusive, irrevocable license to 

AHRQ and those acting on its behalf to 

reproduce, prepare derivative works of, 

and otherwise use the submitted 

materials for the development of AHRQ 

products, including a standardized 

instrument for use in the public 

reporting of family experience of 

pediatric inpatient care; and 

• The right of AHRQ and those acting 

on its behalf to publicly disseminate, in 

any media (including AHRQ’s Web site), 

any derivative works that AHRQ or 

those acting on its behalf develops 

based on the submitted materials. 

Submission Guidelines 

When submitting instruments, please 

include, to the extent that it is available: 

• Name of the instrument; 

• Copies of the full instrument, in all 

languages available; 

• Domains or key concepts included 

in the instrument; 

• Instrument reliability (internal 

consistency, test-retest, etc) and validity 

(content, construct, criterion-related); 

• Results of cognitive testing; 

• Results of field-testing; 

• Current use of the instrument (who 

is using it, what it is being used for, how 

instrument findings are reported, and by 

whom the findings are used); and, 

• Relevant peer-reviewed journal 

articles or full citations. 

When submitting domains, please 

include, to the extent available: 

• Detailed descriptions of question 

domain and specific purpose; 

• Sample questions, in all languages 

available; and, 

• Relevant peer-reviewed journal 

articles or full citations. 

For all submissions, please also 

include: 

• A brief cover letter summarizing the 

information requested above for 

submitted instruments and domains, 

respectively; 

• Complete information about the 

person submitting the material, 

including: 

(a) Name; 

(b) Title; 

(c) Organization; 

(d) Mailing address; 

(e) Telephone number; 

(f) Email address; and, 

(g) The written statement granting 

AHRQ the necessary rights to use, 

modify, and adapt the submitted 

instruments, items, and their supporting 

documentation for the development of 

the survey and its dissemination for 

AHRQ purposes, as described above. 

FOR FURTHER INFORMATION CONTACT: 

Maushami DeSoto, Ph.D., MHA. 

SUPPLEMENTARY INFORMATION: Section 

401(a) of the Children’s Health 

Insurance Program Reauthorization Act 

of 2009 (CHIPRA), public Law 111–3, 

amended the Social Security Act (the 

Act) to enact section 1139A (42 U.S.C. 

1320b–9a). Since the law was passed, 

the Agency for Healthcare Research and 

Quality (AHRQ) and the Centers for 

Medicare & Medicaid Services (CMS) 

have been working together to 

implement selected provisions of the 

legislation related to children’s health 

care quality. Section 1139A(b) of the Act 

charged the Department of Health and 

Human Services with improving 

pediatric health care quality measures. 

To implement the law, AHRQ and CMS 

have established the CHIPRA Pediatric 

Quality Measures Program (PQMP), 

which is designed to enhance select 

pediatric quality measures and develop 

new measures as needed. 

The Children’s Hospital Boston 

Center of Excellence for Pediatric 

Quality Measurement (CEPQM) is one of 

seven CHIPRA PQMP Centers of 

Excellence, which were created 

pursuant to an interagency agreement 

between CMS and AHRQ and funded 

through cooperative agreement awards 

with AHRQ. CEPQM has been assigned 

to develop a family experience of 

pediatric inpatient care measure to be 

considered as a standardized instrument 

for publicly reporting pediatric 

inpatient hospital family experiences 

voluntarily by State Medicaid and CHIP 

programs and to be used by providers, 

consumers, other public and private 

purchasers, and others. The CEPQM 

team is collaborating with the CAHPS 3 

Consortium to develop this instrument. 

Existing instruments or domains 

submitted should capture the family’s 

experience of hospital or related care 

(for example, preparation for discharge 

or care coordination). The survey 

development team is looking for items 

for which families of pediatric 

inpatients are generally the best or only 

judge; for example, the family can best 

say if the provider spent sufficient time 

with them or explained things in ways 

they could understand. Existing 

instruments that have been tested 

should have a high degree of reliability 

and validity; and evidence of wide use 

will be helpful. 

Dated: January 10, 2012. 

Carolyn M. Clancy, 

AHRQ Director. 

[FR Doc. 2012–634 Filed 1–19–12; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–7023–N] 

Medicare, Medicaid, and Children’s 

Health Insurance Programs; Meeting of 

the Advisory Panel on Outreach and 

Education (APOE), February 7, 2012 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces a 

meeting of the Advisory Panel on 

Outreach and Education (APOE) (the 

Panel) in accordance with the Federal 

Advisory Committee Act. The Panel 

advises and makes recommendations to 

the Secretary of Health and Human 

Services and the Administrator of the 

Centers for Medicare & Medicaid 

Services on opportunities to enhance 

the effectiveness of consumer education 


wreier-aviles on DSK5TPTVN1PROD with NOTICES
2984 Federal Register / Vol. 77, No. 13 / Friday, January 20, 2012 / Notices 

strategies concerning Medicare, 

Medicaid, and the Children’s Health 

Insurance Program (CHIP). This meeting 

is open to the public. 

DATES: Meeting Date: Tuesday, February 

7, 2012 from 8:30 a.m. to 4 p.m., Eastern 

Daylight Time (EDT). 

Deadline for Meeting Registration, 

Presentations and Comments: Tuesday, 

January 24, 2012, 5 p.m., EDT. 

Deadline for Requesting Special 

Accommodations: Tuesday, January 24, 

2012, 5 p.m., EDT. 

ADDRESSES: Meeting Location: The 

Embassy Row Hotel, 2015 

Massachusetts Avenue NW., 

Washington, DC 20036. 

Meeting Registration, Presentations, 

and Written Comments: Jennifer 

Kordonski, Designated Federal Official 

(DFO), Division of Forum and 

Conference Development, Office of 

Communications, Centers for Medicare 

& Medicaid Services, 7500 Security 

Boulevard, Mailstop S1–13–05, 

Baltimore, MD 21244–1850 or contact 

Ms. Kordonski via email at mail to: 

Jennifer.Kordonski@cms.hhs.gov. 

Registration: The meeting is open to 

the public, but attendance is limited to 

the space available. Persons wishing to 

attend this meeting must register by 

contacting the DFO at the address listed 

in the ADDRESSES section of this notice 

or by telephone at number listed in the 

FOR FURTHER INFORMATION CONTACT

section of this notice, by the date listed 

in the DATES section of this notice. 

Individuals requiring sign language 

interpretation or other special 

accommodations should contact the 

DFO at the address listed in the 

ADDRESSES section of this notice by the 

date listed in the DATES section of this 

notice. 

FOR FURTHER INFORMATION CONTACT: 

Jennifer Kordonski, (410) 786–1840, or 

on the Internet at http://www.cms.gov/ 

FACA/04_APOE.asp for additional 

information. Press inquiries are handled 

through the CMS Press Office at (202) 

690–6145. 

SUPPLEMENTARY INFORMATION: In 

accordance with section 10(a) of the 

Federal Advisory Committee Act 

(FACA), this notice announces a 

meeting of the Advisory Panel on 

Outreach and Education (APOE) (the 

Panel). Section 9(a)(2) of the Federal 

Advisory Committee Act authorizes the 

Secretary of Health and Human Services 

(the Secretary) to establish an advisory 

panel if the Secretary determines that 

the panel is ‘‘in the public interest in 

connection with the performance of 

duties imposed * * * by law.’’ Such 

duties are imposed by section 1804 of 

the Social Security Act (the Act), 

requiring the Secretary to provide 

informational materials to Medicare 

beneficiaries about the Medicare 

program, and section 1851(d) of the Act, 

requiring the Secretary to provide for 

‘‘activities * * * to broadly disseminate 

information to [M]edicare beneficiaries 

* * * on the coverage options provided 

under [Medicare Advantage] in order to 

promote an active, informed selection 

among such options.’’ 

The Panel is also authorized by 

section 1114(f) of the Act (42 U.S.C. 

1314(f)) and section 222 of the Public 

Health Service Act (42 U.S.C. 217a). The 

Secretary signed the charter establishing 

this Panel on January 21, 1999 (64 FR 

7899, February 17, 1999) and approved 

the renewal of the charter on January 21, 

2011 (76 FR 11782, March 3, 2011). 

Pursuant to the amended charter, the 

Panel advises and makes 

recommendations to the Secretary of 

Health and Human Services and the 

Administrator of the Centers for 

Medicare & Medicaid Services (CMS) 

concerning optimal strategies for the 

following: 

• Developing and implementing 

education and outreach programs for 

individuals enrolled in, or eligible for, 

Medicare, Medicaid, and the Children’s 

Health Insurance Program (CHIP). 

• Enhancing the Federal 

government’s effectiveness in informing 

Medicare, Medicaid, and CHIP 

consumers, providers and stakeholders 

pursuant to education and outreach 

programs of issues regarding these and 

other health coverage programs, 

including the appropriate use of publicprivate partnerships to leverage the 

resources of the private sector in 

educating beneficiaries, providers, and 

stakeholders. 

• Expanding outreach to vulnerable 

and underserved communities, 

including racial and ethnic minorities, 

in the context of Medicare, Medicaid, 

and CHIP education programs. 

• Assembling and sharing an 

information base of ‘‘best practices’’ for 

helping consumers evaluate health plan 

options. 

• Building and leveraging existing 

community infrastructures for 

information, counseling, and assistance. 

• Drawing the program link between 

outreach and education, promoting 

consumer understanding of health care 

coverage choices and facilitating 

consumer selection/enrollment, which 

in turn support the overarching goal of 

improved access to quality care, 

including prevention services, 

envisioned under health care reform. 

The current members of the Panel are: 

Samantha Artiga, Principal Policy 

Analyst, Kaiser Family Foundation; 

Joseph Baker, President, Medicare 

Rights Center; Philip Bergquist, 

Manager, Health Center Operations; 

CHIPRA Outreach & Enrollment Project 

and Director, Michigan Primary Care 

Association, Marjorie Cadogan, 

Executive Deputy Commissioner, 

Department of Social Services; Jonathan 

Dauphine, Senior Vice President, AARP; 

Barbara Ferrer, Executive Director, 

Boston Public Health Commission; 

Shelby Gonzales, Senior Health 

Outreach Associate, Center on Budget & 

Policy Priorities; Jan Henning, Benefits 

Counseling & Special Projects 

Coordinator, North Central Texas 

Council of Governments’ Area Agency 

on Aging; Warren Jones, Executive 

Director, Mississippi Institute for 

Improvement of Geographic Minority 

Health; Cathy Kaufmann, Administrator, 

Oregon Health Authority; Sandy 

Markwood, Chief Executive Officer, 

National Association of Area Agencies 

on Aging; Miriam Mobley-Smith, Dean, 

Chicago State University, College of 

Pharmacy; Ana Natale-Pereira, 

Associate Professor of Medicine, 

University of Medicine & Dentistry of 

New Jersey; Megan Padden, Vice 

President, Sentara Health Plans; David 

W. Roberts, Vice-President, Healthcare 

Information and Management System 

Society; Julie Bode ̈n Schmidt, Associate 

Vice President, National Association of 

Community Health Centers; Alan 

Spielman, President & Chief Executive 

Officer, URAC; Winston Wong, Medical 

Director, Community Benefit Director, 

Kaiser Permanente; and Darlene YeeMelichar, Professor & Coordinator, San 

Francisco State University. 

The agenda for the February 7, 2012 

meeting will include the following: 

• Welcome and Listening Session 

with CMS Leadership; 

• Recap of the Previous (November 

17, 2011) Meeting; 

• Affordable Care Act Initiatives; 

• An opportunity for public 

comment; 

• Meeting Summary, Review of 

Recommendations and Next Steps; 

Individuals or organizations that wish 

to make a 5-minute oral presentation on 

an agenda topic should submit a written 

copy of the oral presentation to the DFO 

at the address listed in the ADDRESSES

section of this notice by the date listed 

in the DATES section of this notice. The 

number of oral presentations may be 

limited by the time available. 

Individuals not wishing to make a 

presentation may submit written 

comments to the DFO at the address 

listed in the ADDRESSES section of this 

notice by the date listed in the DATES

section of this notice. 


wreier-aviles on DSK5TPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 13 / Friday, January 20, 2012 / Notices 2985 

Authority: Sec. 222 of the Public Health 

Service Act (42 U.S.C. 217a) and sec. 10(a) 

of Public Law 92–463 (5 U.S.C. App. 2, sec. 

10(a) and 41 CFR 102–3). 

(Catalog of Federal Domestic Assistance 

Program No. 93.733, Medicare—Hospital 

Insurance Program; and Program No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program) 

Dated: January 5, 2012. 

Marilyn Tavenner, 

Acting Administrator, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2012–594 Filed 1–19–12; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel DDK–C Conflict 

Applications. 

Date: February 21, 2012. 

Time: 5 p.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Thomas A. Tatham, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 760, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–3993, 

tathamt@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: January 13, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–1087 Filed 1–19–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Science Education 

Awards (R–25). 

Date: February 10, 2012. 

Time: 1:30 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817, 

(Telephone Conference Call). 

Contact Person: Richard W. Morris, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, DEA/NIAID/NIH/DHHS, Room 

3251, 6700–B Rockledge Drive, MSC–7616, 

Bethesda, MD 20892–7616, (301) 451–2663, 

rmorris@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 13, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–1112 Filed 1–19–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Initial Review Group; Biological Aging 

Review Committee. 

Date: February 9, 2012. 

Time: 9:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: DoubleTree by Hilton Hotel 

Bethesda, 8120 Wisconsin Avenue, Bethesda, 

MD 20814. 

Contact Person: Bita Nakhai, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, Gateway 

Bldg., 2C212, 7201 Wisconsin Avenue, 

Bethesda, MD 20814, (301) 402–7701, 

nakhaib@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Initial Review Group; Neuroscience of 

Aging Review Committee. 

Date: March 1–2, 2012. 

Time: 8 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavillion, 4300 Military Rd. NW., 

Washington, DC 20015. 

Contact Person: William Cruce, Ph.D., 

Scientific Review Administrator, National 

Institute on Aging, Scientific Review Office, 

Gateway Building 2C–212, 7201 Wisconsin 

Ave., Bethesda, MD 20814, (301) 402–7704, 

crucew@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: January 12, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–1099 Filed 1–19–12; 8:45 am] 

BILLING CODE 4140–01–P 


wreier-aviles on DSK5TPTVN1PROD with NOTICES